An Open-label Bosutinib Treatment Extension Study for Subjects with Chronic Myeloid Leukemia (CML) who have Previously Participated in Bostutinib Studies B1871006 or B1871008

Type of Cancer
Leukemia

Site
Bethesda

Protocol Number
B1871040-1134

To Learn More Call
201-510-0910